MENU
ACRV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Acrivon Therapeutics (ACRV) Ownership - Who owns Acrivon Therapeutics?

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform... Show more

Profile

Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 207-8979
Employees
76
Web
https://www.acrivon.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
68.99M
P/E Ratio
-0.86
Total Cash
89.96M
Projected Growth
N/A
Total Debt
2.12M
Revenue
N/A
Risk (Beta)
2.35
Dividend Yield
N/A
Total Cash/Share
2.10
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Who owns Acrivon Therapeutics? ACRV symbol Ownership - Tickeron.com